https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 The Clinical Impact of Flash Glucose Monitoring-a Digital Health App and Smartwatch Technology in Patients With Type 2 Diabetes: Scoping Review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51305 Wed 28 Feb 2024 16:11:03 AEDT ]]> Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy. https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54979 Wed 27 Mar 2024 09:31:09 AEDT ]]> Diabetes of the exocrine pancreas https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34932 Wed 24 Nov 2021 15:51:46 AEDT ]]> Differential effects of medium- and long-chain saturated fatty acids on blood lipid profile: a systematic review and meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36475 18 y. Where possible, studies were pooled for meta-analysis using RevMan 5.2. The principle summary measure was the mean difference between groups calculated using the random-effects model. Results: Eleven eligible crossover and 1 parallel trial were identified with a total of 299 participants [weighted mean ± SD age: 38 ± 3 y; weighted mean ± SD body mass index (kg/m²): 24 ± 2]. All studies were pooled for the meta-analysis. Diets enriched with MCFAs led to significantly higher high-density lipoprotein (HDL) cholesterol concentrations than diets enriched with LCSFAs (0.11 mmol/L; 95% CI: 0.07, 0.15 mmol/L) with no effect on triglyceride, low-density lipoprotein (LDL) cholesterol, and total cholesterol concentrations. Consumption of diets rich in MCFAs significantly increased apolipoprotein A-I (apoA-I) concentrations compared with diets rich in LCSFAs (0.08 g/L; 95% CI: 0.02, 0.14 g/L). There was no evidence of statistical heterogeneity for HDL cholesterol, apoA-I, and triglyceride concentrations; however, significant heterogeneity was observed for the total cholesterol (I² = 49%) and LDL cholesterol analysis (I² = 58%). Conclusion: The findings of this research demonstrate a differential effect of MCFAs and LCSFAs on HDL cholesterol concentrations. Further investigations are warranted to elucidate the mechanism by which the lipid profile is altered. This trial was registered at www.crd.york.ac.uk/PROSPERO as CRD42017078277.]]> Wed 24 Nov 2021 15:51:06 AEDT ]]> Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41056 10 mmol/L); occurrence of maternal hypoglycaemia (BGL < 3.8 mmol/l) and incidence of neonatal hypoglycaemia (BGL ≤ 2.5 mmol/L). Analysis was stratified by diabetes type. Results: Overall, Pregnancy-IVI achieved a higher proportion of on-IVI time-in-range (70%, IQR 56-78%) compared to Adult-IVI (52%, IQR 41-69%, p < 0.0001). The duration of critical hyperglycaemia with Pregnancy-IVI was also reduced (2% [IQR 0-7] vs 8% [IQR 4-17], p < 0.0001), without an increase in hypoglycaemia. Glycaemic variability was significantly reduced with Pregnancy-IVI. No difference in the rate of neonatal hypoglycaemia was observed. The Pregnancy-IVI was most effective in women with Type 1 diabetes. Conclusion: The Pregnancy-IVI algorithm is safe and effective when used following betamethasone in type 1 diabetes in pregnancy. Further study of women with type 2 diabetes is required.]]> Wed 22 Nov 2023 16:02:08 AEDT ]]> Education of the medical profession to facilitate delivery of transgender health care in an Australian health district https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45424 Wed 22 Mar 2023 18:37:39 AEDT ]]> Evaluation of a type 2 diabetes risk reduction online program for women with recent gestational diabetes: a randomised trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45429 Wed 13 Mar 2024 15:49:55 AEDT ]]> Severe Hypercalcemia in Pregnancy Presenting a Diagnostic Conundrum https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52143 Wed 04 Oct 2023 10:14:18 AEDT ]]> Oestradiol implants for gender-affirming hormone therapy: an observational study of serum oestradiol levels and consumer survey https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54527 Tue 27 Feb 2024 19:43:35 AEDT ]]> The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36640 Tue 25 Oct 2022 09:27:51 AEDT ]]> High-dose preoperative cholecalciferol to prevent post-thyroidectomy hypocalcaemia: A randomized, double-blinded placebo-controlled trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36646 Tue 23 Jun 2020 09:22:45 AEST ]]> The feasibility and preliminary efficacy of an ehealth lifestyle program in women with recent gestational diabetes mellitus: a pilot study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38413 Tue 07 Sep 2021 16:15:37 AEST ]]> A guide to transgender health state-of-the-art information for gender-affirming people and their supporters https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49454 Thu 18 May 2023 11:50:55 AEST ]]> Rural healthcare delivery and maternal and infant outcomes for diabetes in pregnancy: A systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47025 Thu 06 Jul 2023 14:09:44 AEST ]]> Adoption of a pregnancy-specific intravenous insulin protocol (Pregnancy-IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50795 Sat 05 Aug 2023 13:56:55 AEST ]]> Antenatal corticosteroid administration for foetal lung maturation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38469 Mon 29 Jan 2024 18:04:13 AEDT ]]> A collaborative model aligning adult sexual health and endocrine gender health services https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44828 Mon 24 Oct 2022 09:45:47 AEDT ]]> Significance of hyperglycaemia in first trimester pregnancy (SHIFT): A pilot study and literature review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46410 Mon 21 Nov 2022 12:20:45 AEDT ]]> Medium-chain fatty acids lower postprandial lipemia: A randomized crossover trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40753 Mon 18 Jul 2022 13:40:24 AEST ]]> Overweight or obesity increases the risk of cardiovascular disease among older Australian adults, even in the absence of cardiometabolic risk factors: a Bayesian survival analysis from the Hunter Community Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50955 Mon 14 Aug 2023 14:36:36 AEST ]]> Association of Islet Amyloid Polypeptide to C-Peptide Ratio with Cystic Fibrosis-Related Diabetes: A Prospective Cross-sectional Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52281 Mon 09 Oct 2023 10:04:55 AEDT ]]> Oestradiol implants for gender-affirming hormone therapy: an observational study of serum oestradiol levels and consumer survey https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55456 Mon 03 Jun 2024 08:44:05 AEST ]]> Metabolically healthy overweight/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: a systematic review and meta-analysis of prospective cohort studies https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40130 n = 20, I² = 90.3%) and obesity (RR = 1.58, CI: 1.34–1.85, n = 21, I² = 92.2) compared with a reference group with metabolically healthy normal weight. Cardiovascular disease risk was similar irrespective of the number of risk factors used to define metabolically healthy and the risk remained in the group with no metabolic risk factors. Cardiovascular disease risk is increased in populations with overweight and obesity classified as metabolically healthy even when there were no metabolic risk factors.]]> Fri 22 Jul 2022 13:48:22 AEST ]]> Kynurenine, tetrahydrobiopterin, and cytokine inflammatory biomarkers in individuals affected by diabetic neuropathic pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39852 Fri 22 Jul 2022 13:14:52 AEST ]]> Management of metastatic thyroid cancer in pregnancy: risk and uncertainty https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37092 Fri 14 Aug 2020 15:16:50 AEST ]]> Post-operative permanent hypoparathyroidism and preoperative vitamin D prophylaxis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49103 Fri 05 May 2023 11:32:02 AEST ]]> Incidence and Management of Hypertriglyceridemia-Associated Acute Pancreatitis: A Prospective Case Series in a Single Australian Tertiary Centre https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41572 Fri 05 Aug 2022 14:44:39 AEST ]]> eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29549 Fri 03 Dec 2021 10:33:41 AEDT ]]> T lymphocyte and monocyte subsets are dysregulated in type 1 diabetes patients with peripheral neuropathic pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49817 Fri 02 Jun 2023 16:35:22 AEST ]]>